Movement disorders that occurred as late manifestations of Alzheimer’s disease controlled by a low dose of carbamazepine
Introduction: According to the World Health Organization, 44 million people worldwide suffer from Alzheimer’s disease. Abnormal movements are atypical symptoms of Alzheimer’s disease. Case description: An 87-year-old woman, followed for Alzheimer’s disease, experienced abnormal movements. The episod...
Saved in:
Main Authors: | Patrick Manckoundia, Jérémie Vovelle, Sylvia Cancemi, Rachid Mahmoudi, Thomas Renoncourt |
---|---|
Format: | Article |
Language: | English |
Published: |
SMC MEDIA SRL
2024-12-01
|
Series: | European Journal of Case Reports in Internal Medicine |
Subjects: | |
Online Access: | https://www.ejcrim.com/index.php/EJCRIM/article/view/4943 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Second-generation anti-amyloid monoclonal antibodies for Alzheimer’s disease: current landscape and future perspectives
by: Byeong-Hyeon Kim, et al.
Published: (2025-01-01) -
Fighting Alzheimer’s with Movement: The Role of Physical Activity in Disease Management
by: Agnieszka Kosińska, et al.
Published: (2025-02-01) -
Diagnosis of Parkinson’s disease by eliciting trait-specific eye movements in multi-visual tasks
by: Maosong Jiang, et al.
Published: (2025-01-01) -
Amyloid-Related Imaging Abnormalities in Anti-Amyloid Monoclonal Antibody Therapy for Alzheimer’s Disease: Expert Recommendation for Standard MRI Protocol
by: Jimin Kim, et al.
Published: (2025-01-01) -
Low-dose intranasal deferoxamine modulates memory, neuroinflammation, and the neuronal transcriptome in the streptozotocin rodent model of Alzheimer’s disease
by: Jared M. Fine, et al.
Published: (2025-01-01)